News Releases News Releases Year None2022202120202019201820172016 Jan 19, 2022 Sorrento Announces Completion of Enrollment in US Phase 2 Clinical Trial for COVI-DROPS and Achievement of Interim Analysis Threshold in the UK Jan 18, 2022 Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Clinical Trial of COVI-MSC in COVID-19 Patients With Persistent Pulmonary Compromise After Recovery (Long-Hauler) Jan 13, 2022 Sorrento Therapeutics Mexico Wins Tender to Sell COVISTIX Tests to Mexico City Government Jan 07, 2022 Sorrento Therapeutics Announces the Unexpected Death of its Chief Financial Officer Jan 07, 2022 Dr. Henry Ji to Present at HC Wainwright BIOCONNECT Virtual Conference (January 10th – 13th) Jan 04, 2022 Dr. Henry Ji to Participate in Longwood Healthcare Leaders Winter Webconference Panel on January 6th 2022 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Tools Print Print Email Alerts Email Alerts RSS Feeds RSS Feeds Email Page Email Page
News Releases Year None2022202120202019201820172016 Jan 19, 2022 Sorrento Announces Completion of Enrollment in US Phase 2 Clinical Trial for COVI-DROPS and Achievement of Interim Analysis Threshold in the UK Jan 18, 2022 Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Clinical Trial of COVI-MSC in COVID-19 Patients With Persistent Pulmonary Compromise After Recovery (Long-Hauler) Jan 13, 2022 Sorrento Therapeutics Mexico Wins Tender to Sell COVISTIX Tests to Mexico City Government Jan 07, 2022 Sorrento Therapeutics Announces the Unexpected Death of its Chief Financial Officer Jan 07, 2022 Dr. Henry Ji to Present at HC Wainwright BIOCONNECT Virtual Conference (January 10th – 13th) Jan 04, 2022 Dr. Henry Ji to Participate in Longwood Healthcare Leaders Winter Webconference Panel on January 6th 2022 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4
Jan 19, 2022 Sorrento Announces Completion of Enrollment in US Phase 2 Clinical Trial for COVI-DROPS and Achievement of Interim Analysis Threshold in the UK
Jan 18, 2022 Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Clinical Trial of COVI-MSC in COVID-19 Patients With Persistent Pulmonary Compromise After Recovery (Long-Hauler)
Jan 13, 2022 Sorrento Therapeutics Mexico Wins Tender to Sell COVISTIX Tests to Mexico City Government
Jan 07, 2022 Dr. Henry Ji to Present at HC Wainwright BIOCONNECT Virtual Conference (January 10th – 13th)
Jan 04, 2022 Dr. Henry Ji to Participate in Longwood Healthcare Leaders Winter Webconference Panel on January 6th 2022
